Toxic shock syndrome secondary prevention: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Toxic shock syndrome}} | {{Toxic shock syndrome}} | ||
== Overview: == | == Overview: == | ||
Secondary prevention strategies following toxic shock syndrome (TSS) include chemoprophylaxis for invasive group A streptococcus or staphylococcus carriers. Although it is still not certain to be helpful. | [[Secondary prevention]] strategies following [[toxic shock syndrome]] (TSS) include [[chemoprophylaxis]] for invasive group A [[streptococcus]] or [[staphylococcus]] carriers. Although it is still not certain to be helpful. | ||
== Secondary Prevention == | == Secondary Prevention == | ||
Several antibiotic regimens have been successful in eradicating group A streptococcus from the pharynx of chronic carriers (i.e., rifampin plus intramuscular benzathine penicillin or a 10-day course of a second-generation cephalosporin or clindamycin). However, there are limited data concerning chemoprophylaxis for severe invasive group A streptococcal or staphylococcal infections.<ref name="urlSevere Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics">{{cite web |url=http://pediatrics.aappublications.org/content/101/1/136.short |title=Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics |format= |work= |accessdate=}}</ref><ref name="pmid19980033">{{cite journal |vauthors=Wylie A |title=Epithelioma of Soft Palate and Uvula |journal=Proc. R. Soc. Med. |volume=11 |issue=Laryngol Sect |pages=110–1 |year=1918 |pmid=19980033 |pmc=2066844 |doi= |url=}}</ref> | Several [[antibiotic]] regimens have been successful in eradicating group A [[streptococcus]] from the [[pharynx]] of chronic carriers (i.e., [[rifampin]] plus intramuscular [[Benzathine penicillin G|benzathine penicillin]] or a 10-day course of a second-generation [[cephalosporin]] or [[clindamycin]]). However, there are limited data concerning [[chemoprophylaxis]] for severe invasive group A [[Streptococcus|streptococcal]] or staphylococcal infections.<ref name="urlSevere Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics">{{cite web |url=http://pediatrics.aappublications.org/content/101/1/136.short |title=Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics |format= |work= |accessdate=}}</ref><ref name="pmid19980033">{{cite journal |vauthors=Wylie A |title=Epithelioma of Soft Palate and Uvula |journal=Proc. R. Soc. Med. |volume=11 |issue=Laryngol Sect |pages=110–1 |year=1918 |pmid=19980033 |pmc=2066844 |doi= |url=}}</ref> | ||
__NOTOC__ | __NOTOC__ | ||
Revision as of 18:40, 15 May 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
|
Toxic shock syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxic shock syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Toxic shock syndrome secondary prevention |
|
Risk calculators and risk factors for Toxic shock syndrome secondary prevention |
Overview:
Secondary prevention strategies following toxic shock syndrome (TSS) include chemoprophylaxis for invasive group A streptococcus or staphylococcus carriers. Although it is still not certain to be helpful.
Secondary Prevention
Several antibiotic regimens have been successful in eradicating group A streptococcus from the pharynx of chronic carriers (i.e., rifampin plus intramuscular benzathine penicillin or a 10-day course of a second-generation cephalosporin or clindamycin). However, there are limited data concerning chemoprophylaxis for severe invasive group A streptococcal or staphylococcal infections.[1][2]
References
- ↑ "Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics".
- ↑ Wylie A (1918). "Epithelioma of Soft Palate and Uvula". Proc. R. Soc. Med. 11 (Laryngol Sect): 110–1. PMC 2066844. PMID 19980033.